0000899243-20-013018.txt : 20200513
0000899243-20-013018.hdr.sgml : 20200513
20200513180803
ACCESSION NUMBER: 0000899243-20-013018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200511
FILED AS OF DATE: 20200513
DATE AS OF CHANGE: 20200513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Calhoun Lesley Ann
CENTRAL INDEX KEY: 0001730866
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37539
FILM NUMBER: 20874663
MAIL ADDRESS:
STREET 1: C/O GLOBAL BLOOD THERAPEUTICS, INC.
STREET 2: 171 OYSTER POINT BOULEVARD, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc.
CENTRAL INDEX KEY: 0001629137
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274825712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650741-7700
MAIL ADDRESS:
STREET 1: 181 OYSTER POINT BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-11
0
0001629137
Global Blood Therapeutics, Inc.
GBT
0001730866
Calhoun Lesley Ann
C/O GLOBAL BLOOD THERAPEUTICS, INC.
181 OYSTER POINT BLVD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
See Remarks
Common Stock
2020-05-11
4
S
0
381
77.0492
D
3146
D
Common Stock
2020-05-12
4
S
0
2992
78.3798
D
154
D
Represents the weighted average sale price of the shares sold ranging from $78.34 to $78.41 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Title: Senior Vice President, Finance and Chief Accounting Officer
/s/ Lesley Ann Calhoun
2020-05-13